Add to a list

Suspension of trading

Carmat SA Share Price

ALCAR

FR0010907956

Medical Equipment, Supplies & Distribution

OTC Markets Traded

Market Closed - Euronext Paris 10:25:00 19/03/2026 pm IST			5-day change	1st Jan Change
0.0990 ^EUR	-.--%		-.--%	-

01/09	CARMAT SAS Publishes Results Of EFICAS Clinical Study On Aeson Total Artificial Heart As Bridge-To-Transplant Therapy	CI
07/01	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris

Analysts' recommendations: Carmat SA

09/25/09	Carmat: Invest Securities raises target price
11/25/11	Carmat: Invest Securities still a buyer, but cuts TP
04/25/04	Carmat: Invest Securities slightly lowers its target
09/25/09	Carmat: Invest Securities upgrades to buy
09/25/09	Carmat: Oddo BHF reduces its price target

More recommendations

News in other languages: Carmat SA

04/03	Carmat, Ynsect… quand les pépites industrielles françaises tombent dans le gouffre de Moore
07/01	Pluxee N : Carmat, Hoffmann, LDC, Pluxee, Technip Energies... les valeurs à suivre aujourd'hui à Paris
07/01	Bourse : GTT et Technip Energy engrangent, Pluxee publie, Carmat disparaît
07/01	CARMAT : A suivre aujourd'hui
07/01	Les records continuent à tomber en bourse

More news

Managers and Directors: Carmat SA

Manager	Title	Age	Since
Stéphane Piat CEO	Chief Executive Officer	55	01/09/2016
Pascale d’Arbonneau DFI	Director of Finance/CFO	-	12/12/2018
Christian Latrémouille CTO	Chief Tech/Sci/R&D Officer	-	01/04/2025

Director	Title	Age	Since
Stéphane Piat BRD	Director/Board Member	55	-
Jean-Luc Lemercier BRD	Director/Board Member	68	02/01/2017
Michael Mack BRD	Director/Board Member	79	20/04/2017

More insiders

Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

Employees

153

Sector

Medical Equipment, Supplies & Distribution

More about the company

Stock Market
Stocks
ALCAR Stock

-40%: Exceptional extension

SEIZE THE OFFER!

Market Cap	61.46L 70.33L 57.76L 52.71L 98.93L 67Cr 98.95L 6.93Cr 2.68Cr 34Cr 2.64Cr 2.58Cr 110.68Cr	P/E 2023	-3.09x	P/E 2024	-0.95x
Enterprise Value	5.92Cr 6.78Cr 5.57Cr 5.08Cr 9.54Cr 648.1Cr 9.54Cr 67Cr 26Cr 330.97Cr 25Cr 25Cr 1.07TCr	EV / Sales 2023	56.1x	EV / Sales 2024	13.5x
Free-Float	89.06%	Yield 2023 *	-	Yield 2024	-

01/09	CARMAT SAS Publishes Results Of EFICAS Clinical Study On Aeson Total Artificial Heart As Bridge-To-Transplant Therapy	CI
07/01	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris
07/01	CARMAT: To Watch Today
06/01	Carmat, GTT, Genfit, LDC... Stocks to Watch Tomorrow in Paris
06/01	Carmat Announces Liquidation and Delisting
02/12	Only Takeover Bid for Carmat Approved by Court
02/12	Carmat: Takeover Offer Approved, 88 Jobs Saved	RE
02/12	Carmat receives takeover bid	RE
04/11	Carmat SAS submits bid for Carmat SA within ongoing receivership procedure	RE
15/25/15	CAC 40 Surges on LVMH Results and Easing US-China Tensions
15/25/15	Carmat: Judicial Recovery Continues, New Hearing Set for November 25	RE
15/25/15	Carmat says liquidation review postponed until Nov 25	RE
01/25/01	Carmat: Judicial Liquidation Request to Be Reviewed on October 14	RE

02/12	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
04/11	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
29/25/29	CARMAT : Inside Information / Other news releases	PU
29/25/29	CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)	BU
15/25/15	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU

Current year	0.1	0.1
1 year	0.1	0.11
3 years	0.08	9.99
5 years	0.08	30.8
10 years	0.08	40.06

Date	Insider	Type	Main position	Quantity	% Market Cap.
13/03/25	Pierre Bastid	Sell	Chairman	13,43,333	2.3347%
13/03/25	Pierre Bastid	Buy	Chairman	13,43,333	2.3347%
29/05/24	Antonino Ligresti	Buy	Director	13,43,333	4.6122%

Carmat SA Share Price

Stocks

ALCAR

FR0010907956

Medical Equipment, Supplies & Distribution

Valuation: Carmat SA

Chart: Carmat SA

Latest news: Carmat SA

Analysts' recommendations: Carmat SA

Press Releases: Carmat SA

News in other languages: Carmat SA

Price Extremes

Managers and Directors: Carmat SA

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARMAT SA	-.--%	-.--%	-9.17%	-98.65%	70.8L
STRYKER CORPORATION	+0.33%	-2.28%	-27.27%	-3.57%	11TCr
SMITH & NEPHEW PLC	-0.34%	-1.72%	-24.84%	-0.77%	1.16TCr
GLAUKOS CORPORATION	-1.03%	-6.88%	+88.92%	+112.35%	952.32Cr
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-0.52%	+5.55%	-50.01%	-66.86%	422.39Cr
DOUBLE MEDICAL TECHNOLOGY INC.	+2.40%	+3.36%	-24.63%	+25.14%	239.25Cr
INSPIRE MEDICAL SYSTEMS, INC.	-5.84%	-4.42%	-9.21%	-61.46%	218.91Cr
INSIGHT LIFETECH CO., LTD.	+1.53%	+7.78%	-	-	195.53Cr
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-0.58%	+2.75%	-19.33%	-27.67%	155.33Cr
Average	-0.43%	+1.37%	-9.44%	-15.19%	1.54TCr
Weighted average by Cap.	+0.11%	-2.15%	-19.24%	+2.08%

	2023	2024
Net sales	38.37L 43.91L 36.06L 32.91L 61.76L 42Cr 61.78L 4.33Cr 1.67Cr 21Cr 1.65Cr 1.61Cr 69Cr	73.44L 84.04L 69.02L 62.99L 1.18Cr 80Cr 1.18Cr 8.28Cr 3.2Cr 41Cr 3.16Cr 3.09Cr 132.26Cr
Net income	-5.39Cr -6.16Cr -5.06Cr -4.62Cr -8.67Cr -589.28Cr -8.67Cr -61Cr -23Cr -300.93Cr -23Cr -23Cr -970.15Cr	-5.14Cr -5.88Cr -4.83Cr -4.41Cr -8.27Cr -562.22Cr -8.27Cr -58Cr -22Cr -287.11Cr -22Cr -22Cr -925.59Cr
Net Debt	4.96Cr 5.68Cr 4.67Cr 4.26Cr 7.99Cr 542.98Cr 7.99Cr 56Cr 22Cr 277.29Cr 21Cr 21Cr 893.91Cr	5.31Cr 6.08Cr 4.99Cr 4.55Cr 8.55Cr 580.87Cr 8.55Cr 60Cr 23Cr 296.64Cr 23Cr 22Cr 956.3Cr